Internal Medicine, Infectious Disease · Columbia, MO
NPI
1700236882
Since 2016
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1705 E Broadway Ste 300
Columbia, MO, 65201
Phone (573) 815-3550
Groups this clinician bills Medicare through
Medicare paid, 2024
$120K
1,520 services
Medicare patients, 2024
467
Average age 75
Drug cost, 2024
$963K
1,335 prescriptions
Company payments, 2025
$1,622
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Phillip P Beck was code 99232 (hospital e&m - subsequent), 520 times for 214 patients. In total Phillip P Beck billed 1,520 services in 21 codes, and Medicare paid $120K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 520 | 214 | $58.37 | $30K |
| 99222 Hospital E&M - Initial | Facility | 190 | 166 | $92.24 | $18K |
| 99213 Office E&M - Established | Office | 179 | 126 | $61.83 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 178 | 104 | $86.33 | $15K |
| 99223 Hospital E&M - Initial | Facility | 174 | 158 | $125.09 | $22K |
| 99214 Office E&M - Established | Office | 157 | 103 | $84.60 | $13K |
| 99203 Office E&M - New | Office | 38 | 38 | $79.29 | $3,013 |
| 99204 Office E&M - New | Office | 35 | 35 | $113.61 | $3,976 |
By year: 2022 $106K for 1,270 services; 2023 $100K for 1,298 services; 2024 $120K for 1,520 services.
Medicare prescription drug claims, 2024
In 2024, the drug Phillip P Beck prescribed most often to Medicare patients was Cefadroxil, with 241 prescriptions and refills. In total Phillip P Beck wrote 1,335 Medicare prescriptions that cost $963K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cefadroxil Generic | 241 | 303 | 52 | $9,812 |
| Amoxicillin Generic | 132 | 159 | 23 | $1,281 |
| Doxycycline Hyclate Generic | 122 | 163 | 45 | $2,749 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 121 | 121 | 14 | $478K |
| Cephalexin Generic | 55 | 55 | 26 | $1,586 |
| Rifampin Generic | 53 | 66 | 20 | $3,223 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 53 | 58 | 33 | $979 |
| Ceftriaxone Ceftriaxone Sodium | 38 | 38 | 11 | $2,117 |
| Cefazolin Sodium Generic | 33 | 33 | 12 | $2,516 |
| Dovato Dolutegravir Sodium/Lamivudine | 29 | 29 | Under 11 | $84K |
| Azithromycin Generic | 27 | 35 | Under 11 | $240 |
| Fluconazole Generic | 25 | 27 | 11 | $454 |
| Doxycycline Monohydrate Generic | 19 | 23 | Under 11 | $260 |
| Ampicillin Sodium Generic | 18 | 18 | Under 11 | $6,840 |
| Levofloxacin Generic | 17 | 17 | Under 11 | $102 |
Brand drugs: 226 claims; generic drugs: 1,109 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Phillip P Beck $1,622 ($1,622 in general payments such as food, travel and fees) from 21 companies. The largest payer was ViiV Healthcare Company with $351.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 18 | $351 |
| Aimmune Therapeutics, Inc. | 10 | $200 |
| Merck Sharp & Dohme LLC MRK | 8 | $184 |
| Recordati_rare_diseases_inc. | 5 | $167 |
| Abbvie Inc. ABBV | 4 | $101 |
| Gilead Sciences, Inc. GILD | 5 | $96.14 |
| Insmed, Inc. INSM | 4 | $83.33 |
| Xeris Pharmaceuticals, Inc. | 3 | $63.81 |
| Corcept Therapeutics CORT | 2 | $61.85 |
| Melinta Therapeutics, LLC | 3 | $50.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.